Search - tctmd.com

Displaying 981 - 1000 of 1032

Sort: Relevancy | Date

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

News Daily News

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

March 25, 2013

News Industry News

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 11, 2013

Presentation TCT 2013

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye, Mark Webster, James Stewart, Alexandre Abizaid, RICARDO COSTA, Jose Costa Jr, John Yan, vinayak bhat, lynn morrison, Sara Toyloy, John Ormiston

January 31, 2013

News Industry News

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 07, 2013

News Daily News

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

December 17, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

Presentation TCT 2012

TCT-563: Multicenter First-in-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND...

Presenter: Takashi Muramatsu

October 23, 2012

Presentation TCT 2012

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

Presenter: Yoshinobu Onuma

October 23, 2012

Presentation TCT 2012

TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence...

Presenter: Christos Bourantas

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

TCT-33. Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The...

Presenter: Vasim Farooq

October 23, 2012

Presentation TCT 2012

Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future!

Presenter: Jean-Fran?ois Tanguay

October 23, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

October 16, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

October 16, 2012

Advertisement

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Abbott Initiates Clinical Trial of Absorb™ in the United States

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

TCT-563: Multicenter First-in-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND...

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

TCT-37. Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in...

TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence...

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

TCT-33. Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The...

Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future!

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content